These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 17356951)
1. Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors? Yoon SS; Tanabe KK Ann Surg Oncol; 2007 Jun; 14(6):1784-6. PubMed ID: 17356951 [No Abstract] [Full Text] [Related]
2. [Current aspects of treatment in gastrointestinal stromal tumors (GIST)]. Láng I; Hitre E Orv Hetil; 2005 May; 146(18 Suppl 1):935-41. PubMed ID: 15921308 [TBL] [Abstract][Full Text] [Related]
3. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases]. Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842 [TBL] [Abstract][Full Text] [Related]
6. The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor. Wang JP; Wang T; Huang MJ; Wang L; Kang L; Wu XJ Am J Clin Oncol; 2011 Jun; 34(3):314-6. PubMed ID: 20622646 [TBL] [Abstract][Full Text] [Related]
8. Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST). Hohenberger P; Eisenberg B Ann Surg Oncol; 2010 Oct; 17(10):2585-600. PubMed ID: 20407930 [TBL] [Abstract][Full Text] [Related]
9. [Gastrointestinal stromal tumor (GIST): pathology in continuous development. Diagnostic-therapeutic strategies]. Sianesi M Ann Ital Chir; 2009; 80(4):257-60. PubMed ID: 19967882 [No Abstract] [Full Text] [Related]
10. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case. Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500 [TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087 [TBL] [Abstract][Full Text] [Related]
12. Is there a role for neoadjuvant treatment with Gleevec for large rectal gastrointestinal stromal tumors? Wasserberg N; Nunoo-Mensah JW; Beart RW; Ker TS Int J Colorectal Dis; 2007 Aug; 22(8):981-2. PubMed ID: 16583196 [No Abstract] [Full Text] [Related]
13. Adjuvant and neoadjuvant therapy for primary GIST. Eisenberg BL; Smith KD Cancer Chemother Pharmacol; 2011 Jan; 67 Suppl 1():S3-8. PubMed ID: 21116626 [TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced gastrointestinal stromal tumor: a marriage of targeted therapy and surgery? DeMatteo RP Ann Surg Oncol; 2007 Jan; 14(1):1-2. PubMed ID: 16957967 [No Abstract] [Full Text] [Related]
15. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors. Seshadri RA; Rajendranath R J Cancer Res Ther; 2009; 5(4):267-71. PubMed ID: 20160360 [TBL] [Abstract][Full Text] [Related]
16. Nonadherence to imatinib treatment in patients with gastrointestinal stromal tumors: the ADAGIO study. Mazzeo F; Duck L; Joosens E; Dirix L; Focan C; Forget F; De Geest S; Muermans K; VAN Lierde MA; Macdonald K; Abraham I; De Grève J Anticancer Res; 2011 Apr; 31(4):1407-9. PubMed ID: 21508393 [TBL] [Abstract][Full Text] [Related]
17. [Gastrointestinal stromal tumours: a broad spectrum of clinical presentations]. Pacelli F; Rosa F; Papa V; Tortorelli AP; Sanchez AM; Covino M; Sofo L; Doglietto GB Chir Ital; 2007; 59(6):771-9. PubMed ID: 18360981 [TBL] [Abstract][Full Text] [Related]
18. Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. Blay JY; Le Cesne A; Ray-Coquard I; Bui B; Duffaud F; Delbaldo C; Adenis A; Viens P; Rios M; Bompas E; Cupissol D; Guillemet C; Kerbrat P; Fayette J; Chabaud S; Berthaud P; Perol D J Clin Oncol; 2007 Mar; 25(9):1107-13. PubMed ID: 17369574 [TBL] [Abstract][Full Text] [Related]